↓ Skip to main content

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, October 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
Published in
Frontiers in oncology, October 2021
DOI 10.3389/fonc.2021.684070
Pubmed ID
Authors

Yan Hu, Si-Ying Ren, Ruo-Yao Wang, Chao Zeng, Ji-Na Li, Peng Xiao, Fang Wu, Feng-Lei Yu, Wen-Liang Liu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 10%
Other 2 7%
Student > Doctoral Student 2 7%
Student > Bachelor 2 7%
Student > Master 2 7%
Other 2 7%
Unknown 17 57%
Readers by discipline Count As %
Medicine and Dentistry 8 27%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Nursing and Health Professions 2 7%
Immunology and Microbiology 1 3%
Unknown 17 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2023.
All research outputs
#8,575,549
of 26,163,973 outputs
Outputs from Frontiers in oncology
#3,213
of 22,913 outputs
Outputs of similar age
#160,424
of 441,628 outputs
Outputs of similar age from Frontiers in oncology
#162
of 1,469 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,628 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 1,469 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.